Skip to content
Condition

Beta Thalassemia

Beta thalassemia is a genetic blood disorder where your body makes less hemoglobin (a protein in red blood cells) or abnormal hemoglobin. Hemoglobin carries oxygen throughout your body. When you don't have enough healthy hemoglobin, your red blood cells can't carry enough oxygen, leading to anemia and other health problems. The severity varies greatly among individuals.

What is Beta Thalassemia?

Beta thalassemia is a genetic blood disorder that affects your body's ability to produce normal hemoglobin. Hemoglobin is a vital protein in red blood cells responsible for carrying oxygen from your lungs to all parts of your body. When you have beta thalassemia, your body makes too little or faulty hemoglobin, leading to a shortage of healthy red blood cells and a condition called anemia.

Your red blood cells contain hemoglobin, which is like a tiny oxygen taxi. In beta thalassemia, the "taxi" isn't built correctly or there aren't enough of them. This means your blood cannot deliver enough oxygen to your tissues and organs. The severity of beta thalassemia depends on which specific gene changes you have inherited. There are different types, ranging from mild (beta thalassemia minor or trait) to severe (beta thalassemia major, also known as Cooley's anemia). People with beta thalassemia minor usually have no symptoms or very mild anemia. Those with beta thalassemia major experience severe anemia and serious health complications from early childhood, requiring lifelong medical care. Beta thalassemia intermedia falls between these two extremes.

Symptoms

Symptoms of beta thalassemia vary widely depending on the type you have. People with mild forms (beta thalassemia minor) often have no symptoms. Those with more severe forms (beta thalassemia major or intermedia) typically develop signs of anemia, such as fatigue and weakness, starting in early childhood.

For individuals with beta thalassemia major, symptoms usually appear within the first two years of life. These can include severe tiredness (fatigue), weakness, pale skin, and shortness of breath due to severe anemia. Other signs may include yellow skin (jaundice), dark urine, and slow growth. The body may try to make more red blood cells, leading to an enlarged spleen, liver, or heart. Bone problems, especially in the face and skull, can also develop. People with beta thalassemia intermedia have milder symptoms than those with major, but they can still experience fatigue, bone changes, and an enlarged spleen. They might need blood transfusions only occasionally, unlike those with major thalassemia who need them regularly.

Causes & risk factors

Beta thalassemia is a genetic disorder caused by changes (mutations) in the genes that control the production of beta-globin, a part of hemoglobin. You inherit these gene changes from your parents. It is not contagious and cannot be caught from another person.

Hemoglobin is made of two main parts: alpha-globin and beta-globin. In beta thalassemia, there's a problem with the genes responsible for making beta-globin. If you inherit one changed gene from one parent, you have beta thalassemia minor (also called beta thalassemia trait) and are a carrier. If you inherit two changed genes, one from each parent, you will develop a more severe form, such as beta thalassemia major or intermedia. This inheritance pattern is called autosomal recessive. Risk factors for beta thalassemia include having a family history of the condition. It is also more common in people of Mediterranean, South Asian, Southeast Asian, and African descent. This is because the gene changes are more prevalent in these populations.

How it's diagnosed

Beta thalassemia is diagnosed through various blood tests that check for anemia and examine the hemoglobin in your red blood cells. Genetic testing can confirm the diagnosis and identify the specific gene changes responsible for the condition.

A complete blood count (CBC) is often the first test. It measures the number of red blood cells, their size, and the amount of hemoglobin they contain. In beta thalassemia, red blood cells are typically smaller and paler than normal, and hemoglobin levels are low. Another important test is hemoglobin electrophoresis or high-performance liquid chromatography (HPLC). These tests separate the different types of hemoglobin in your blood and measure their amounts. This helps identify abnormal hemoglobin patterns characteristic of beta thalassemia. Genetic testing (DNA analysis) can precisely identify the specific gene mutations causing beta thalassemia. This is especially useful for confirming the diagnosis, determining the type of thalassemia, and for genetic counseling for families. Prenatal testing can also be done during pregnancy.

Treatment options

Treatment for beta thalassemia depends on its severity. People with mild forms usually don't need treatment. For severe forms, common treatments include regular blood transfusions to provide healthy red blood cells and iron chelation therapy to remove excess iron that builds up from transfusions.

Regular blood transfusions are the primary treatment for beta thalassemia major. These transfusions provide healthy red blood cells, which help to correct anemia and improve oxygen delivery. However, frequent transfusions can lead to a dangerous buildup of iron in the body. To prevent iron overload, iron chelation therapy is essential. This treatment uses medications, taken orally or by injection, to remove excess iron from the body. Managing iron levels is crucial to protect organs like the heart, liver, and endocrine glands from damage. In some cases, a stem cell transplant (also known as a bone marrow transplant) may offer a cure, especially for children with severe beta thalassemia. This procedure involves replacing the unhealthy bone marrow with healthy stem cells from a compatible donor. Splenectomy (surgical removal of the spleen) may also be considered if an enlarged spleen is destroying too many red blood cells.

Recovery & outlook

The outlook for beta thalassemia varies significantly based on its severity and the effectiveness of treatment. With proper, lifelong medical management, including regular transfusions and iron chelation, individuals with severe beta thalassemia can live longer and healthier lives than in the past.

For people with beta thalassemia minor, the outlook is excellent, as they typically have no significant health problems and a normal life expectancy. They usually do not require specific treatment for the condition. For those with beta thalassemia major, consistent adherence to treatment plans is vital. Regular blood transfusions and diligent iron chelation therapy help manage symptoms and prevent serious complications like heart failure, liver damage, and bone problems. Advances in medical care have greatly improved the quality of life and life expectancy for individuals with severe beta thalassemia. While it requires ongoing management, many can lead fulfilling lives. A stem cell transplant offers a potential cure, but it carries risks and requires a suitable donor.

When to see a doctor

You should see a doctor if you or your child develop symptoms of anemia, such as persistent fatigue, unusual paleness, or shortness of breath, especially if you have a family history of thalassemia or are of a high-risk ethnic background.

Seek immediate medical attention if you experience severe symptoms like extreme weakness, difficulty breathing, or yellowing of the skin and eyes (jaundice). These could indicate severe anemia or other complications requiring urgent care. If you are a carrier of beta thalassemia (beta thalassemia minor) and are planning to have children, it is important to speak with your doctor or a genetic counselor. They can help you understand the risks of passing the condition to your children and discuss options for family planning. For individuals already diagnosed with beta thalassemia, it is crucial to follow your treatment plan diligently and attend all scheduled appointments. Report any new or worsening symptoms, fever, or signs of infection to your healthcare team promptly.

Frequently asked questions

Can beta thalassemia be cured?

For most people, beta thalassemia is a lifelong condition that can be managed but not cured. However, a stem cell transplant (also known as a bone marrow transplant) can offer a cure for some individuals, particularly children with severe forms, if a suitable donor is found.

Is beta thalassemia contagious?

No, beta thalassemia is not contagious. It is a genetic disorder, meaning it is inherited from your parents through their genes. You cannot catch it from another person like a cold or flu.

What is the difference between beta thalassemia minor and major?

Beta thalassemia minor (or trait) means you have inherited one gene change and usually have no or very mild symptoms. Beta thalassemia major means you have inherited two gene changes, one from each parent, leading to severe anemia and serious health problems requiring lifelong treatment.

How does iron overload happen in beta thalassemia?

Iron overload primarily occurs in severe beta thalassemia due to frequent blood transfusions, which are necessary to treat anemia. Each unit of transfused blood contains iron, and over time, this iron builds up in the body's organs, potentially causing damage.

Can beta thalassemia be prevented?

Beta thalassemia itself cannot be prevented because it is a genetic condition. However, genetic counseling can help individuals and couples understand their risk of having a child with a severe form of thalassemia and explore family planning options.

What are the long-term complications of beta thalassemia?

Without proper treatment, long-term complications can include heart problems (like heart failure), liver damage, bone deformities, delayed growth, and endocrine issues (problems with hormone-producing glands). These are often due to severe anemia or iron overload.

Sources

  • MedlinePlus — Beta Thalassemia
  • Mayo Clinic — Beta Thalassemia
  • Cochrane Library — Beta Thalassemia
KA
Medical reviewer
Kathy Bacon

Reviewed this article for medical accuracy (2026-06-05).